According to Mereo BioPharma Group's latest financial reports the company's current earnings (TTM) are -HK$0.28 B. In 2022 the company made an earning of -HK$0.31 B a decrease over its 2021 earnings that were of HK$0.19 B.The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.